Chinese man spends $600,000 on hair salon detox treatments, suffers severe health issues and denied refund
(Also read: Chinese teen narrowly escapes death after eating only vegetables and laxatives to fit into birthday dress)
The man, surnamed Cheng, first encountered the salon's team in April 2023 in Hefei, where a manager named Chen invited him to the launch of a new salon branch. During the visit, another manager, surnamed Zhou, coaxed him upstairs to try what was described as a beautician's massage. That moment marked the beginning of a relentless campaign of sales pressure, Cheng said.
Aggressive sales tactics and emotional manipulation
Cheng claimed he was repeatedly persuaded to top up his salon account under emotional pressure. 'They were all young boys and girls, kneeling and saying they were poor and couldn't even afford rent, relying on customers to help support their parents,' he recounted. 'Older beauticians nearby would consistently urge customers to top up, stating that the staff earned commissions based on performance.'
The account balance continued to rise sharply. One record showed a single top-up of 388,000 yuan (US$54,000) in January, while by March 30, the balance had swelled to over 1.7 million yuan.
Unlicensed treatments and mounting health complications
Among the services offered were 'skin-breaking needle detox,' massages priced at 500–600 yuan per body part, and 'belly dampness removal' costing up to 2,000 yuan per session. Cheng said he also underwent multiple enema sessions, marketed as 'bowel cleansing,' with one course costing around 300,000 yuan (US$42,000).
The salon promised benefits such as weight loss and a more youthful appearance. However, instead of rejuvenation, Cheng developed severe health issues including chronic diarrhoea and persistent needle marks that failed to heal. Upon discovering that the salon had no medical licence to administer such procedures, he demanded a refund—which was refused.
Authorities step in
Following the incident, Cheng lodged a complaint with the authorities. According to SCMP, on July 9, Hefei police confirmed that a joint investigation had been launched with market supervision officials into the salon's alleged unlicensed medical practices.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
6 hours ago
- Mint
Unfulfilled dreams: Suicide cases rise for people in their 30s; no, it's not just depression
Financial stress, caregiving duties and career demands are causing burnout among Singaporeans in their 30s. Experts warn that this 'sandwich generation' faces rising suicide rates. In 2024, 75 people aged 30-39 died by suicide, up from 66 in 2023. This was the highest for any age group. Samaritans of Singapore say these adults encounter unique pressures. They have unstable jobs, family issues and mental health problems. Dr Sharon Lu thinks suicide usually results from a combination of factors, not just depression. 'It is often assumed that depression is the cause of all suicides, but suicide is often due to the interaction of a myriad of factors and life circumstances,' the South China Morning Post quoted Lu as saying. 'Depression may be one of the many stressors an individual is struggling with, but someone who is not depressed can still be suicidal,' she added. People in their 30s may be vulnerable to severe emotional strain. They have to manage multiple responsibilities. They need to manage careers, children, ageing parents and financial commitments. According to Lu, juggling parenting, relationships and elderly care deeply impacts mental health in their 30s. The pressure of meeting society's expectations adds to isolation. Psychiatrist Dr David Teo believes disappointment from unmet life goals creates feelings of failure. He said comparing lives with others on social media increases stress and feelings of being left behind. 'Goals and dreams from their 20s that remain unfulfilled can lead to a sense of failure or hopelessness,' SCMP quoted him as saying. Also, physical health problems and new mental health conditions often emerge in this difficult life stage, according to Teo. The concern is not only about people in Singapore. Recent data shows Indians aged between 30 and 44 face a rising suicide risk. In 2022, people aged 18–30 accounted for 35% of suicides, followed closely by those aged 30–45 at 32%. Together, these age groups made up 67% of all suicide deaths. Suicides in India increased from 1,64,033 in 2021 to 1,70,924 in 2022, according to NCRB data. Cities reported higher suicide rates compared to the national average. Family problems (31.7%), illness (18.4%) and marriage issues (4.8%) accounted for over half the suicides. Men made up 71.8% of victims. Tamil Nadu reported the highest mass suicide cases, followed by Rajasthan, Andhra Pradesh and Karnataka. If you or someone you know is struggling with suicidal thoughts, reaching out to a suicide helpline can provide immediate, confidential and compassionate support. Here are some of those: KIRAN Helpline: 1800-599-0019
The Print
7 hours ago
- The Print
Mounjaro, Wegovy signal ashift in obesity care model in India which sees 20k bariatric surgeries a year
Mounjaro, manufactured by US-based Eli Lilly & Company and which has tirzepatide as its active pharmaceutical ingredient (API), was launched in India 20 March. Wegovy, a weight loss drug by Danish drugmaker Novo Nordisk which has semaglutide as its API, hit the Indian markets 25 June. But the development has another fallout that has become a talking point among physicians treating and managing obesity—a possible reduction in the number of bariatric surgeries or weight loss surgery, a series of procedures intended to reshape or alter the anatomy of the stomach to reduce weight. New Delhi: The back-to-back arrival of two high-profile weight loss drugs in India, Mounjaro and Wegovy, over the past four months has fuelled an intense competition in the country's burgeoning anti-obesity market as one megaseller tries to outshine the other. The prescription-only drugs mimic the effects of the natural gut hormones that work by lowering caloric intake, primarily by influencing appetite control mechanisms, and can result in weight of up to 15-20 percent. Many clinicians say this will lead to fewer people opting for bariatric surgeries, which, depending on the extent and type of the surgery, result in a moderate 15 percent to a high of over 50 percent weight loss. 'As Wegovy and Mounjaro are now available for patients struggling with obesity, I see fewer patients opting for bariatric surgeries, especially the simpler procedures which are also more common, as they offer nearly comparable weight loss results,' Dr Naval K. Vikram, a professor of medicine and obesity researcher at the All India Institute of Medical Sciences in New Delhi, told ThePrint. His colleague, a bariatric surgeon at the premium institute who did not want to be named, also said the number of adjustable gastric banding and gastric sleeve surgeries, which are less complex but also result in moderate weight loss, could particularly take a hit. As per statistics shared by the Obesity and Metabolic Surgery of India (OSSI), India has over the past five to seven years consistently performed around 20,000 bariatric surgeries a year. 'While patient hesitation was common in the early years, growing awareness about the broader health benefits of bariatric surgery, along with the introduction of advanced technologies such as robotic-assisted surgery, has encouraged more individuals to consider it,' said Dr Sukhvinder Singh Saggu, the national convener of the OSSI national registry. A last year study examining a large sample of patients with obesity in the US found that the usage of anti-obesity drugs doubled from 2022 to 2023 in the country, and there was a sharp decline (25.6 percent) in the number of patients undergoing metabolic bariatric surgery to treat obesity. Most physicians see the trend getting repeated in India in the coming months. India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore, and is projected to grow nearly eightfold to Rs 25,000 crore by 2030 as per the market estimates. Also Read: Oil is making India obese and import-hungry. Modi wants to change that Someone's gain, someone's loss Chennai-based diabetologist Dr V. Mohan, an obesity researcher and the chairman of the Madras Diabetes Research Foundation (MDRF), said the advent of new age weight loss drugs marks a paradigm shift in obesity management, similar to what the arrival of drug classes such as proton pump inhibitors (that reduce stomach acid production) meant for the fate of peptic ulcer surgeries. 'At one point, procedures such as gastrojejunostomy for patients of peptic ulcers were very common but these procedures are barely needed now. I see a similar shift in the bariatric surgery landscape and these procedures would increasingly be reserved for people with very high body mass index (BMI),' Mohan said. Bariatric surgery is generally considered for individuals with a Body Mass Index (BMI) of 40 or higher, or for those with a BMI of 35 or higher and serious obesity-related health problems. These health problems can include type 2 diabetes, high blood pressure, or severe sleep apnea. In some cases, surgery may also be an option for individuals with a BMI between 30 and 34 who have poorly controlled type 2 diabetes. But in Indians, where in several people BMI of even nearly 30 can cause a problem due to fat deposition near vital organs, surgery is sometimes indicated. A 2023 survey by the Indian Council of Medical Research (ICMR) and Madras Diabetes Research Foundation (MDRF) had shown that 25.4 crore Indians had generalised obesity. A large number of people have body weight exceeding BMI of over 35 and body weight of even 100 kg and above, say doctors. In such patients, the surgery works by altering the digestive system to reduce food intake and/or absorption, leading to weight loss and improvement of obesity-related health issues. In comparison, Mounjaro and Wegovy primarily influence appetite control mechanisms. In May this year, Lilly said in a statement that a head-to-head clinical trial comparing tirzepatide and semaglutide in their maximum tolerable dosages showed the former to be significantly more effective in reducing both weight and waist circumference after 72 weeks of treatment. According to the U.S. based pharma giant, the participants administered tirzepatide saw an average weight reduction of 20.2 percent, while those on semaglutide experienced a 13.7 percent loss—indicating a 47 percent greater relative weight loss for the former, based on the treatment-regimen estimand at 72 weeks. But some doctors said while tirzepatide is better than semaglutide in percentage of weight loss, there is stronger evidence in case of semaglutide for reducing cardiovascular conditions in obese people without diabetes and also for treating kidney and diabetes. Dr Naval K. Vikram, the AIIMS professor quoted above said, for people who opted for simpler bariatric surgeries, which also meant lesser complications but relatively lower weight loss result, these drugs will be a likelier choice. 'Their cost,' he said, 'however could be a dampener as they are expensive and will need recurring expenses.' The monthly cost of the first three dosing strengths of Wegovy, which are typically the starting dosages, has been kept at Rs 17,345, the last two dose strengths or the maintenance dose cost Rs 24,280 and Rs 26,050 respectively. The starting dose of Maunjaro, on the other hand, costs Rs 14,000 per month while the higher dose costs Rs 17,500 per month. But Mohan countered that surgeries do not come cheap either and generally cost Rs 2 lakh to even more than Rs 6 lakh. 'Plus, these procedures are complicated, cause permanent changes in the stomach structure and sometimes patients tend to regain weight later on for which they need therapeutic intervention,' he said. Step up for obesity management On their part, metabolic and obesity surgeons maintained that these surgeries are no longer seen merely as a weight-loss procedure but widely recognised as a powerful therapeutic tool for managing a range of obesity-related conditions, including type 2 diabetes, coronary artery disease, hypertension, high cholesterol, infertility, and sleep apnea. The integration of robotic systems has further enhanced outcomes by offering greater precision, faster recovery, and improved patient comfort, Dr Sukhvinder Singh Saggu said. Surgeons also insisted that the approach to obesity treatment in India is also evolving into a multimodal strategy, similar to cancer care where surgery, chemotherapy, and radiotherapy work in tandem. 'Given that obesity is a complex, chronic, and multifactorial condition, the treatment now combines weight loss drugs, lifestyle management, exercise, and bariatric surgery, tailored to the patient's BMI and health profile,' Saggu said. 'So we do not see these (anti-obesity medications) as a challenge to bariatric surgery. Instead, these drugs complement surgical options, broadening the spectrum of treatments available,' he also said. Both approaches have their limitations, but together they form part of a comprehensive obesity management pathway designed to deliver sustained health benefits, the OSSI member further said. Dr Parimuthukumar, a senior consultant in minimally invasive gastrointestinal and bariatric surgery at Prashanth Hospitals in Chennai, pointed out that patients are assessed based on their BMI, which categorises them as overweight, obese (Class 1, 2, 3), or even super obese. 'Bariatric surgery is never the first line of treatment. When a patient comes in, we always begin by recommending dietary changes and lifestyle modifications,' he said. Not all patients, however, are able to follow through successfully and in such cases, surgeons may consider weight-loss medications, depending on the patient's suitability. 'Only when both non-invasive options do not yield the desired results, and if the patient meets clinical criteria, do we proceed with bariatric surgery,' Parimuthukumar said, adding that it's a gradual, stepwise approach. 'Whichever method is used — diet, drugs, or surgery — weight loss happens over time, not overnight. But ultimately, reaching a healthier weight improves patients' physical mobility and often reduces their dependence on medication,' he said. (Edited by Ajeet Tiwari) Also Read: Obesity care in India is evolving—no longer just diets & surgery, it's all about multi-specialty approach
&w=3840&q=100)
First Post
a day ago
- First Post
‘1 in 5 children in Gaza City is malnourished': Where's the food aid?
After 21 months of the Israel war, the people in Gaza are facing acute shortages of food, resulting in 'mass starvation' and causing unprecedented levels of malnourishment. What's behind this humanitarian crisis in the Palestinian area? read more A little infant's body rests on the table at Gaza City's Al Shifa hospital. As hospital staff remove the clothing off the infant's body what they see is appalling — protruding ribs and hollow stomach. But the tiny toddler isn't a one-off case. Extreme hunger is resulting in malnutrition and deaths in the besieged enclave with the UN's Palestinian refugee agency (UNRWA) saying that one in five children in Gaza City is malnourished and cases are increasing every day. STORY CONTINUES BELOW THIS AD In a statement issued on Thursday, Unrwa Commissioner-General Philippe Lazzarini cited a colleague telling him: 'People in Gaza are neither dead nor alive, they are walking corpses.' But why is this happening? Why are all 2.1 million people in Gaza are now food insecure? GHF: Few sites and deadly violence Israel's chosen aid distributor, the Gaza Humanitarian Foundation (GHF), began operations on May 26 after a more than two-month total aid blockade. Now the main channel for distributing food to Gaza, GHF has faced chaos and deadly violence at its few distribution points. The United Nations and aid groups have refused to work with GHF, saying it was created to serve Israeli military interests. 'They are not a humanitarian organisation… You don't deliver humanitarian aid in areas that have been completely flattened and militarised,' said Arwa Damon, founder of INARA, a US-based NGO offering medical and mental health support to children. She noted the GHF's site locations — along two military corridors in southern and central Gaza — rather than being spread out across the territory. Displaced Palestinians receive donated food at a community kitchen in Gaza City, northern Gaza Strip. AP Today, there are only four GHF sites in Gaza — Tal al-Sultan, Saudi neighbourhood, Khan Younis and Wadi Gaza. These are open only for eight minutes at a time and in June, the average for the Saudi site was 11 minutes. This has led to many to allege that system is dangerous by design. The Unrwa chief, Philippe Lazzarini, even said 'the so-called mechanism … is a death trap costing more lives than it saves.' In fact, according to UN figures, Israeli forces have killed nearly 900 desperate and hungry Gazans near GHF sites until July 13. Israel has rejected calls to restore the UN-led system, citing concerns that Hamas looted trucks and resold aid meant to be distributed free of charge. Aid organisations sidelined Another reason for the dire conditions in Gaza according to international aid groups is Israel itself. They note that vast quantities of food are stockpiled outside Gaza but await clearance from the Israeli military. Furthermore, inside Gaza, coordination with the military is also essential, as fighting and air strikes rage on. Damon accuses Israel of preventing aid delivery by refusing to coordinate with NGOs to grant safe passage through combat zones. STORY CONTINUES BELOW THIS AD 'Getting that coordination approved is incredibly challenging,' she told AFP. 'Not to mention Israel's lack of willingness to provide humanitarian organisations with a safe route to be able to ensure a secure pickup.' The UN agency for Palestinian refugees, UNRWA, said on Wednesday it had 'thousands of trucks in neighbouring countries waiting to enter Gaza — banned by Israeli authorities from entering since March'. Displaced Palestinian mother Samah Matar holds her malnourished son Youssef, who suffers from cerebral palsy, at a school where they shelter amid a hunger crisis, in Gaza City. Reuters Israel blames UN However, the Jewish nation denies limiting the number of humanitarian trucks into Gaza. On Thursday, it even posted footage online of hundreds of trucks with aid 'sitting idle inside Gaza'. Moreover, Israel's Foreign Minister Gideon Sa'ar told Politico that Israel had opened up more crossing points and was allowing more aid to enter Gaza under a deal struck with the European Union. He added that the problem was that the UN was failing to distribute more than 900 truckloads of aid parked in a fenced-off area near the Kerem Shalom crossing point in the Gaza Strip. 'The problem is the UN is not distributing [aid],' said Sa'ar. 'There are more than 900 trucks waiting … inside Gaza Strip, and they are just not distributing them to the people in Gaza.' STORY CONTINUES BELOW THIS AD UN agencies and international NGOs reject Israeli claims that they lack the capacity to distribute food. They note that aid was distributed effectively in the past, including during the last ceasefire in the Israel-Hamas war that ended in March. A father clings to the body of his infant who died of starvation according to health officials, in Gaza City. Reuters 'There's just no food' For people in Gaza, this has resulted in a nightmare. The few doctors inside Gaza say the mounting hunger crisis is horrific is hitting women and children the hardest. As American surgeon Ambereen Sleemi told NBC News that the neonatal intensive care unit was 'full of babies that are malnourished that have struggled to get formula or get feeding.' She added that in many cases the lack of nutrition had led to other health complications, including a surge in infection rates. Elidalis Burgos, an American critical care nurse volunteering in Gaza, further told NBC News that she had witnessed 'an entire population' suffering from starvation because of the Israeli blockade. 'There's just no food,' said Burgos, who is working at Nasser Hospital in Khan Younis. 'There is just nothing getting in, hasn't been getting in for months.' Walaa Fathi, a resident of Gaza who is eight months pregnant, wailed about the situation, saying that Gazans were 'experiencing a catastrophe and a famine that no one could have imagined'. 'I hope that my baby stays in my womb and I don't have to give birth in these difficult circumstances,' she was quoted as telling the BBC from Deir al-Balah. STORY CONTINUES BELOW THIS AD With inputs from AFP and agencies
